These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27155683)
21. Helicobacter pylori treatment: Still a work in progress. Senatore FJ; Wilmot J; Birk JW Postgrad Med; 2016 Jan; 128(1):152-7. PubMed ID: 26490697 [TBL] [Abstract][Full Text] [Related]
22. H. pylori should be eradicated in chronic liver disease patients with peptic ulcer. Zullo A; Cristofari F; Hassan C Dig Liver Dis; 2009 Feb; 41(2):141-2. PubMed ID: 19112053 [No Abstract] [Full Text] [Related]
23. Evidence-based recommendations for successful Helicobacter pylori treatment. Wu JY; Liou JM; Graham DY Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):21-8. PubMed ID: 24410470 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
25. Practical Aspects in Choosing a Helicobacter pylori Therapy. Molina-Infante J; Shiotani A Gastroenterol Clin North Am; 2015 Sep; 44(3):519-35. PubMed ID: 26314666 [TBL] [Abstract][Full Text] [Related]
26. IV Spanish Consensus Conference on Helicobacter pylori infection treatment. Gisbert JP; Molina-Infante J; Amador J; Bermejo F; Bujanda L; Calvet X; Castro-Fernández M; Cuadrado-Lavín A; Elizalde JI; Gene E; Gomollón F; Lanas Á; Martín de Argila C; Mearin F; Montoro M; Pérez-Aisa Á; Pérez-Trallero E; McNicholl AG Gastroenterol Hepatol; 2016 Dec; 39(10):697-721. PubMed ID: 27342080 [TBL] [Abstract][Full Text] [Related]
27. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Gisbert JP; Calvet X Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749 [TBL] [Abstract][Full Text] [Related]
28. Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Lee MW; Kim GH Gut Liver; 2022 Nov; 16(6):807-808. PubMed ID: 36379903 [No Abstract] [Full Text] [Related]
29. Practice guidelines for treatment of peptic ulcer disease. Webb DD JAMA; 1996 Oct; 276(14):1136; author reply 1136-7. PubMed ID: 8827959 [No Abstract] [Full Text] [Related]
31. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042 [TBL] [Abstract][Full Text] [Related]
33. The who's and when's of therapy for Helicobacter pylori. Graham DY; Börsch GM Am J Gastroenterol; 1990 Dec; 85(12):1552-5. PubMed ID: 2252013 [No Abstract] [Full Text] [Related]
34. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori. Yazbek PB; Trindade AB; Chin CM; Dos Santos JL Dig Dis Sci; 2015 Oct; 60(10):2901-12. PubMed ID: 25999247 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848 [TBL] [Abstract][Full Text] [Related]
36. [History of the treatment of Helicobacter pylori and clinical efficacy]. Yamamoto I; Fukuda Y; Shimoyama T Nihon Rinsho; 1999 Jan; 57(1):32-42. PubMed ID: 10036933 [TBL] [Abstract][Full Text] [Related]
37. H. pylori Infection: ACG Updates Treatment Recommendations. Randel A Am Fam Physician; 2018 Jan; 97(2):135-137. PubMed ID: 29365220 [No Abstract] [Full Text] [Related]
39. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure. Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy. Lee SK; Lee SW; Park JY; Kwon BS; Kim SY; Hyun JJ; Kim JH; Jung SW; Koo JS; Yim HJ; Choi JH Helicobacter; 2011 Oct; 16(5):410-4. PubMed ID: 21923688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]